Axsome Therapeutics, Inc. (19X)
Market Closed
3 Jun, 20:00
€
200. 70
+10.2
+5.35%
€
- Market Cap
- P/E Ratio
- Div Yield
48 Volume
-4.27 Eps
€ 190.5
Previous Close Want to track 19X and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
19X Earnings Reports FAQ
What is the earnings per share (EPS) for 19X?
The current EPS is -4.27.
What is the company's earnings growth rate?
Axsome Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Axsome Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Axsome Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 19X at this time, as Axsome Therapeutics, Inc has no recent EPS data to calculate it.
